Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)

BACKGROUND: A recent randomized placebo-controlled trial of the effect of atorvastatin treatment on the progression of newly diagnosed type 1 diabetes suggested a slower decline of residual beta cell function with statin treatment. Aim of this secondary analysis was to identify patient subgroups whi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Strom, Alexander, Kolb, Hubert, Martin, Stephan, Herder, Christian, Simon, Marie-Christine, Koenig, Wolfgang, Heise, Tim, Heinemann, Lutz, Roden, Michael, Schloot, Nanette C.
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3308960/
https://ncbi.nlm.nih.gov/pubmed/22448235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0033108
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares